How big is the gene therapy market?

The global gene therapy market size was estimated at USD 5.54 billion in 2023 and is expected to reach USD 6.45 billion in 2024.

What is the gene therapy market growth?

The global gene therapy market is expected to grow at a compound annual growth rate of 18.88% from 2024 to 2030 to reach USD 18.20 billion by 2030.

Which segment accounted for the largest gene therapy market share?

North America dominated the gene therapy market with a share of 18.95% in 2023. This is attributable to rising healthcare awareness coupled with the growing demand for robust therapeutics to treat chronic illness.

Who are the key players in the gene therapy market?

Some key players operating in the gene therapy market include Amgen Inc., Novartis AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., bluebird bio, Inc., Bristol-Myers Squibb Company, and Legend Biotech among others

What are the factors driving the gene therapy market?

Key factors that are driving the gene therapy market growth include recent approval of products such as Zolgensma and Vyjuvek which has accelerated investment in clinical trials of pipeline programs.